SplitJul 31, 2026, 08:08 AM
Aethlon Medical Announces 1-for-5 Reverse Stock Split
AI Summary
Aethlon Medical, Inc. announced a 1-for-5 reverse stock split of its common stock, effective July 31, 2026. The company expects its common stock to begin trading on a split-adjusted basis on The Nasdaq Capital Market on August 4, 2026. This action is part of the company's capital-markets plan, including compliance with Nasdaq listing rules and dilution management. Post-split, authorized shares will be reduced to 20,000,000, and outstanding shares will be approximately 649,914.
Key Highlights
- Aethlon Medical filed a Certificate of Change for a 1-for-5 reverse stock split.
- The reverse stock split becomes effective on July 31, 2026, at 10:00 a.m. Eastern Time.
- Common Stock is expected to begin trading on a split-adjusted basis on August 4, 2026.
- The split aims to maintain compliance with Nasdaq Listing Rule 5550(a)(2) and manage dilution.
- Authorized shares will decrease from 100,000,000 to 20,000,000 post-split.
- Outstanding shares will be approximately 649,914 after the split, from 3,249,569.
- No fractional shares will be issued; stockholders will receive one whole share for any fractional entitlement.
Price Impact
More from AEMD